Stroke Management: An Emerging Role of Nanotechnology
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Stroke is among the leading causes of mortality and morbidity worldwide. Stroke incidences and associated mortality are expected to rise to 23 million and 7.8 million, respectively, by 2030. Further, the aging population, imbalanced lifestyles, and environmental factors continue to shift the rate of stroke incidence, particularly in developing countries. There is an urgent need to develop new therapeutic approaches for treating stroke. Nanotechnology is a growing field, offering an encouraging future prospect for medical research in the management of strokes. The world market for nanotechnology derived products is expected to rise manyfold in the coming decades. Different types of nanomaterials such as perfluorocarbon nanoparticles, iron oxide nanoparticles, gold nanoparticles, polymeric nanoparticles, quantum dots, nanospheres, etc. have been developed for the diagnosis as well as therapy of strokes. Today, nanotechnology has also been integrated with stem cell therapy for treating stroke. However several obstacles remain to be overcome when using such nanomaterials for treating stroke and other neurological diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
O'Donnell, M. J., Xavier, D., Liu, L., Zhang, H., Chin, S. L., Rao-Melacini, P., Rangarajan, S., Islam, S., Pais, P., McQueen, M. J., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60834-3 · Cited by 3,448 · cited 1×
“Risk factors such as hypertension, dyslipidemia, diabetes, smoking, poor diet, and lack of physical activity constitute up to 80% of stroke cases [7].”
BackgroundNanomedicine: current status and future prospects
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029 · cited 1×
“NPs are a result of numerous physical or chemical processes, and these possess specific properties [22].”
BackgroundFeigin, V. L., Roth, G. A., Naghavi, M., Parmar, P., Krishnamurthi, R., Chugh, S., Mensah, G. A., Norrving, B., Shiue, I., Ng, M., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30073-4 · Cited by 1,691 · cited 1×
“Still, an attempt was made by the 2013 Global Burden of Disease (GBD) study, revealing stroke to be the second leading cause of death behind only cardiovascular diseases [2].”
BackgroundChallenges in Development of Nanoparticle-Based Therapeutics
Desai, N. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9339-4 · Cited by 1,173 · cited 1×
“This would further exacerbate the condition by creating more blood vessel occlusions [41], and, in severe conditions, dissemination due to intravascular coagulation may occur [70].”
BackgroundDobrovolskaia, M. A., Aggarwal, P., Hall, J. B., & McNeil, S. E. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800032f · Cited by 1,022 · cited 1×
“To perpetuate this problem further, the lysed haemoglobin and cell debris may attach to circulating nanomaterials and trigger an immune cascade, which has been previously shown to be a cause of non-cerebrovascular occlusive stroke [69].”
BackgroundWeinstein, J. S., Varallyay, C. G., Dosa, E., Gahramanov, S., Hamilton, B., Rooney, W. D., Muldoon, L. L., & Neuwelt, E. A. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.192 · Cited by 500
Wang, B., Yantsen, E., Larson, T., Karpiouk, A. B., Sethuraman, S., Su, J. L., Sokolov, K., & Emelianov, S. Y. (2009) · Nano Letters · doi:10.1021/nl801852e · Cited by 208
Cited by
The Hemocompatibility of Nanoparticles: A Review of Cell–Nanoparticle Interactions and Hemostasis
de la Harpe, K., Kondiah, P., Choonara, Y., Marimuthu, T., du Toit, L., & Pillay, V. (2019) · Cells · doi:10.3390/cells8101209 · Cited by 368
Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB
Satapathy, M. K., Yen, T.-L., Jan, J.-S., Tang, R.-D., Wang, J.-Y., Taliyan, R., & Yang, C.-H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081183 · Cited by 318
“An advanced nanodrug delivery approach may contribute a novel treatment strategy to overcome the major hurdles during drug targeting for stroke management [264].”
Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs
Naqvi, S., Panghal, A., & Flora, S. J. S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00494 · Cited by 305
Formation, antimicrobial activity, and biomedical performance of plant-based nanoparticles: a review
Nguyen, N. T. T., Nguyen, L. M., Nguyen, T. T. T., Nguyen, T. T., Nguyen, D. T. C., & Tran, T. V. (2022) · Environmental Chemistry Letters · doi:10.1007/s10311-022-01425-w · Cited by 175
Metadata
- Authors
- Sarmah, D., Saraf, J., Kaur, H., Pravalika, K., Tekade, R., Borah, A., Kalia, K., Dave, K., & Bhattacharya, P.
- Venue
- Micromachines
- Publisher
- MDPI AG
- Published
- 2017-08-28
- Volume
- 8
- Issue
- 9
- Pages
- 262
- ISSN
- 2072-666X (ISSN-L)
- OpenAlex
- W2750229176
- Cited by
- 48
- References
- 7
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Stroke Management: An Emerging Role of Nanotechnology. https://app.cochat.ai/papers/10.3390/mi8090262
- The paper
- Sarmah, D., Saraf, J., Kaur, H., Pravalika, K., Tekade, R., Borah, A., Kalia, K., Dave, K., & Bhattacharya, P. (2017). Stroke Management: An Emerging Role of Nanotechnology. Micromachines. https://doi.org/10.3390/mi8090262
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.